Exosome-based strategies to enhance CAR-T cell therapy for systemic lupus erythematosus: A promising new frontier
{{output}}
Dysregulated B lymphocyte activation plays a pivotal role in the pathogenesis of systemic lupus erythematosus (SLE), making it a promising target for therapeutic intervention. Chimeric antigen receptor T cell (CAR-T) therapy, specifically targeting CD19-positi... ...
